Glucosylceramide

N/A

Report date: 2022/11/18 18:20:45
NME

Base Information

Drug NameGlucosylceramide
Drug Alias NameGC葡糖神经酰胺葡萄糖脑苷脂GlcCer葡糖苷酰鞘氨醇 +[9] 
ClassificationNatural product/ExtractSmall molecules > Carbohydrate
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnzo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzoHadassah Medical Organization
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCrohn Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG